Works matching IS 14363291 AND DT 2015 AND VI 18 AND IP 4


Results: 23
    1
    2
    3
    4
    5

    Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer.

    Published in:
    Gastric Cancer, 2015, v. 18, n. 4, p. 824, doi. 10.1007/s10120-014-0420-9
    By:
    • Satoh, Taroh;
    • Lee, Kyung;
    • Rha, Sun;
    • Sasaki, Yasutsuna;
    • Park, Se;
    • Komatsu, Yoshito;
    • Yasui, Hirofumi;
    • Kim, Tae-You;
    • Yamaguchi, Kensei;
    • Fuse, Nozomu;
    • Yamada, Yasuhide;
    • Ura, Takashi;
    • Kim, Si-Young;
    • Munakata, Masaki;
    • Saitoh, Soh;
    • Nishio, Kazuto;
    • Morita, Satoshi;
    • Yamamoto, Eriko;
    • Zhang, Qingwei;
    • Kim, Jung-mi
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23